Daunomac-20

Generic Name – Daunorubicin
Drug Class – Antineoplastic agent
Daunorubicin is an anthracycline chemotherapy drug used to treat acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL).
It works by interfering with DNA replication, leading to the death of rapidly dividing cancer cells.
Daunorubicin is given by intravenous (IV) injection, usually in combination with other chemotherapies.
It is a key component of induction therapy in leukemia treatment protocols.
Common side effects include hair loss, low blood counts, and heart-related toxicity.

Dosage 

• Available in 20 mg strength